Literature DB >> 27815237

Betting on hepatitis C: how financial speculation in drug development influences access to medicines.

Victor Roy1, Lawrence King2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27815237     DOI： 10.1136/bmj.i3718

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The Treatment of Hepatitis C- An Introduction to the Use of New Medicines.

Authors:  Bernhard Wörmann
Journal:  Dtsch Arztebl Int       Date:  2017-01-09       Impact factor: 5.594

2.  Accelerating Innovation in the Creation of Biovalue: The Cell and Gene Therapy Catapult.

Authors:  John Gardner; Andrew Webster
Journal:  Sci Technol Human Values       Date:  2017-04-06

3.  Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies.

Authors:  Kiu Tay-Teo; André Ilbawi; Suzanne R Hill
Journal:  JAMA Netw Open       Date:  2019-01-04

4.  Biotechnological Potential of Bacteria Isolated from the Sea Cucumber Holothuria leucospilota and Stichopus vastus from Lampung, Indonesia.

Authors:  Joko T Wibowo; Matthias Y Kellermann; Dennis Versluis; Masteria Y Putra; Tutik Murniasih; Kathrin I Mohr; Joachim Wink; Michael Engelmann; Dimas F Praditya; Eike Steinmann; Peter J Schupp
Journal:  Mar Drugs       Date:  2019-11-08       Impact factor: 5.118
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.